focus -WSS

focus

author：Wikipedia 2025-08-08 08:10:11 - browse：81

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Biotech venture capitalists face new demands from investors

WSS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

RaDonda Vaught to speak at CommonSpirit event on patient safety

Francis Collins on trust in science and how Covid communications failed

Scientists unlock the key to scar

Change Healthcare cyberattack outage could last weeks

Humana cuts profit projections as Medicare Advantage costs soar

focus

focus

hotspot

Walensky prepares to leave CDC — and Congress — behind

How digital therapeutics firms are pivoting after Pear's bankruptcy

Cancer drug shortages should be causing more outrage

eGenesis tests gene

23andMe had bad news about my health. I wish a person had delivered it

Eli Lilly, Pfizer, and others want in on the online prescription market

Supreme Court strikes down use of affirmative action

AI generated plenty of interest at JPM but not a lot of trust

Medical leaders decry Supreme Court decision on affirmative action

EU regulator recommends expanding Mounjaro approval to obesity

leisure time

How digital therapeutics firms are pivoting after Pear's bankruptcy

FDA clears AI tool for detecting skin cancer

How digital therapeutics firms are pivoting after Pear's bankruptcy

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Dewpoint Therapeutics lays off staff after losing partnerships

New brain studies show LSD's effects on the brain in full color

entertainment

knowledge

hotspot

focus